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Recent studies have shown that, during cell death,
the protein Omi is released from the mitochondrial
intermembrane space into the cytosol, where it aug-
ments caspase-dependent apoptosis by blocking
inhibitors and may induce caspase-independent cell
death via its serine protease activity.
Apoptosis is a conserved cellular suicide program that
eradicates excess or potentially dangerous cells; its
many important physiological functions include termi-
nating immune responses and eliminating virally
infected or cancerous cells [1]. The induction of apop-
tosis relies critically on the mitochondria, as these
organelles release apoptogenic factors that activate
caspases, a family of proteinases that kill the cell via
proteolysis of key substrates [2]. Recent studies [3–6]
have shed new light on this process and shown that,
during cell death, mitochondria release a protein
known as Omi into the cytosol. In the cytosol, Omi
augments caspase activation by blocking endogenous
caspase inhibitors and may also activate caspase-
independent death pathways through its serine pro-
tease activity.
Two main pathways have been defined that initiate
caspase activation (Figure 1) [2]. The first begins at the
cell surface and involves ligand-induced activation of
death receptors, such as TNFRI and Fas, which then
recruit and activate caspases. The second involves
mitochondrial integration of cellular stress signals and
subsequent release into the cytosol of cytochrome c,
which activates caspases via the adapter molecule
‘apoptotic protease activating factor-1’ (APAF-1). In
certain cell types (Type II cells), the induction of apop-
tosis appears to require amplification by mitochondria
of the initial death receptor signal (Figure 1) [7].
Mitochondria thus play a critical part in the induction
of apoptosis by cellular stress and often by death
receptors.
Inhibitor of apoptosis proteins (IAPs) such as XIAP,
cIAP-1, and cIAP-2 block apoptosis by inactivating
caspases (Figure 1) [8]. IAPs contain ‘baculovirus IAP
repeat’ (BIR) domains, which directly inhibit caspases,
and a RING finger domain, which promotes caspase
degradation via the ubiquitin–proteasome pathway.
Not surprisingly, cells have ways to overcome this IAP
block and thereby ‘let slip the dogs of war’ — the
caspases. One mechanism involves the mitochondrial
protein Smac/DIABLO, which binds and inhibits IAPs
[9,10]. During apoptosis, mitochondria release
Smac/DIABLO into the cytosol, where it potentiates
caspase activation by binding IAPs through an amino-
terminal AVPI motif. The four new papers [3–6] identify
Omi as a second mitochondrial protein released into
the cytosol during apoptosis that binds and inhibits
IAPs. Strikingly, however, Omi is also a serine
protease that may induce caspase-independent cell
death.
Each of the groups that identified Omi [3–6] used an
affinity chromatography strategy to purify XIAP (or
XIAP-BIR3) binding proteins; in each case, the
approach yielded both Smac/DIABLO and the novel
protein Omi. The 36 kDa Omi is derived from a 50 kDa
precursor which has three distinct domains: an amino-
terminal mitochondrial translocation sequence (MTS),
a trypsin-like protease domain, and a carboxy-
terminal PDZ domain (Figure 2). The Omi precursor
resides in the mitochondria, where it undergoes auto-
catalytic removal of the MTS to generate the mature
36 kDa form. Strikingly, sequence analysis of mature
Omi revealed a putative amino-terminal IAP-binding
motif (AVPS) similar to that found in Smac/diabolo,
caspase-9 and the Drosophila proteins Reaper, Hid
and Grim (Figure 2) [9–14]. Subsequent studies con-
firmed that this motif allows Omi to bind IAPs and
suppress their caspase-inhibitory activity in cell-free
apoptosis assays. Moreover, apoptotic stimuli were
found to induce release of Omi into the cytosol, where
it binds IAPs and appears to enhance caspase-depen-
dent apoptosis (Figure 1, green pathway). Deletion or
mutation of Omi’s AVPS motif completely prevented
its interaction with IAPs, but failed to completely
abolish its death inducing activity, suggesting that
Omi acts as more than an IAP-binding protein.
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Figure 1. Cell death pathways modulated by Omi.
Caspase-dependent (green) and caspase-independent (blue)
cell death pathways regulated by mitochondria. Smac/Diablo
and Omi may function in both pathways, whereas cytochrome
c appears to function primarily to activate caspases. (See text
for details.)
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Sequence analysis identified a trypsin-like serine
protease domain in Omi, and this activity was
confirmed by experiments demonstrating that Omi
cleaves casein [3,5]. XIAP did not inhibit Omi’s
protease activity, suggesting that the protease activity
may also function in death induction. Unlike the wild-
type protein, forms of Omi lacking both IAP-binding
and protease activities could not induce spontaneous
cell death or augment chemotherapy-induced apopto-
sis. But mutants retaining either IAP-binding or pro-
tease activity could enhance cell death [5,6]. Strikingly,
death induction by overexpression of Omi protease
activity was not blocked by the caspase inhibitor
ZVAD-fmk [3,6] and occurred in APAF-1 or caspase-9
null cells [6]. These observations indicate that Omi can
induce caspase-independent cell death independently
of its IAP-binding activity (Figure 1, blue pathway).
Why might Omi have two distinct death-inducing
activities? The IAP-inhibiting activity of Omi may lower
a cell’s apoptotic threshold by amplifying low levels of
caspase activation. This might be particularly impor-
tant for Type II cells, which require mitochondrial
amplification of death-receptor signals for apoptosis
induction. Omi’s death-inducing serine protease activ-
ity may ensure cell death when inhibitors, mutation or
deletion have inactivated caspase pathways. This may
also be the case for Smac-β, a cell-death-inducing
Smac isoform that does not bind IAPs [15]. The signif-
icance of these caspase-independent death pathways
remains unclear, as they have both been defined by
overexpression studies. Additionally, although trypsin-
like protease inhibitors block cell death in certain
circumstances, several serine proteases of broad
specificity can induce cell death or activate caspases
in vitro when present at high concentration [16–18].
Identification of Omi substrates and the development
of Omi-specific inhibitors and Omi-deficient knockout
mice will aid in the validation of Omi’s caspase-
independent death activity.
The known function of Omi’s bacterial homologue
‘high temperature requirement A’ (HtrA) as both a
chaperone and protease suggest that Omi might also
act in cellular stress responses [19]. HtrA acts as a
molecular chaperone that participates in protein re-
folding at low temperatures. At high temperatures,
however, HtrA has essentially no chaperone activity
and instead it functions as a protease that degrades
misfolded proteins. In this light, it is tempting to
speculate that Omi may act as a mitochondrial
chaperone in the absence of cellular stress, but may
switch function and act as a serine death protease
when activated by cellular stress.
In support of this idea, upregulation of Omi protease
activity was observed during the stress invoked by
kidney ischemia [20]. Stress-activated kinases are one
potential way of controlling the switch in Omi function
— Omi indeed has a potential stress kinase
phosphorylation site (SPRS) at amino acid 142 (Figure
2). Besides modulating Omi’s proteolytic activity,
phosphorylation might modify Omi’s IAP-inhibiting
activity, cellular localization and ability to induce
caspase-independent cell death. These possibilities
suggest that Omi may not just ‘let slip the dogs of war’
during apoptosis, but also plays a much broader role
in controlling cellular life and death.
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Figure 2. Omi and related IAP-binding
proteins.
(A) The Omi domain structure highlighting
the mitochondrial translocation sequence
(MTS), the trypsin-like protease domain
and the PDZ domain (which may function
in protein–protein interactions. AVPS is
the IAP-binding motif, and SPRS the
putative stress kinase phosphorylation
site. (B) A comparison of IAP-binding
motifs defined to date.
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